Name and surname:
|
doc. MUDr. Pavol Janega, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Assistant, Assistant Professor, Associate Professor (2022-current position) | Comenius University, Faculty of Medicine, Bratislava | 2002-current employment |
doctor - pathologist | University Hospital in Bratislava | 2002-current employment |
researcher, independent researcher (qualification level IIa) | Slovak Academy of Sciences, Centre of Experimental Medicine, Institute of Normal and Pathological Physiology, Bratislava | 2003-current employment |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
postgraduate course in diagnostic molecular pathology | Medical University of Graz | 2006 |
specialisation, certified in Pathological Anatomy | Slovak Medical University, Faculty of Medicine | 2003 |
scientific qualification level IIa | Slovak Academy of Sciences | 2010 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Pathological Anatomy 1 + 2 in Slovak and English | General Medicine | II | General Medicine |
Pathological Anatomy 1 + 2 in Slovak and English | Dentistry | II | General Medicine |
Pathological anatomy | Biomedical physics | II | Physics (major) and General Medicine (minor) |
Clinical pathology | General Medicine | II | General Medicine |
Pathological physiology and pathology - new trends | All Doctoral Study Programmes at Fac.of Medicine | III | General Medicine and Dentistry |
Plava, J., M. Burikova, M. Cihova, L. Trnkova, B. Smolkova, P. Babal, L. Krivosikova, P. Janega, L. Rojikova, S. Drahosova, M. Bohac, L. Danisovic, L. Kucerova and S. Miklikova (2021). "Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer." J Exp Clin Cancer Res 40(1): 302.
Kodada, D., M. Hyblova, P. Krumpolec, N. Janostiakova, P. Barath, M. Grendar, G. Blandova, O. Petrovic, P. Janega, V. Repiska and G. Minarik (2023). "The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study." Int J Mol Sci 24(9).
Sykora, T., P. Babal, K. Mikus-Kuracinova, F. Drafi, S. Ponist, M. Dvorakova, P. Janega and K. Bauerova (2021). "Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis." Int J Mol Sci 22(16).
Stanko, P., T. Baka, K. Repova, S. Aziriova, K. Krajcirovicova, A. Barta, P. Janega, M. Adamcova, L. Paulis and F. Simko (2020). "Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension." Front Med (Lausanne) 7: 325.
Barta, A., P. Janega, P. Babal, E. Murar, M. Cebova and O. Pechanova (2015). "The effect of curcumin on liver fibrosis in the rat model of microsurgical cholestasis." Food Funct 6(7): 2187-2193.
Plava, J., M. Burikova, M. Cihova, L. Trnkova, B. Smolkova, P. Babal, L. Krivosikova, P. Janega, L. Rojikova, S. Drahosova, M. Bohac, L. Danisovic, L. Kucerova and S. Miklikova (2021). "Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer." J Exp Clin Cancer Res 40(1): 302.
Sykora, T., P. Babal, K. Mikus-Kuracinova, F. Drafi, S. Ponist, M. Dvorakova, P. Janega and K. Bauerova (2021). "Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis." Int J Mol Sci 22(16).
Stanko, P., T. Baka, K. Repova, S. Aziriova, K. Krajcirovicova, A. Barta, P. Janega, M. Adamcova, L. Paulis and F. Simko (2020). "Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension." Front Med (Lausanne) 7: 325.
Kodada, D., M. Hyblova, P. Krumpolec, N. Janostiakova, P. Barath, M. Grendar, G. Blandova, O. Petrovic, P. Janega, V. Repiska and G. Minarik (2023). "The Potential of Liquid Biopsy in Detection of Endometrial Cancer Biomarkers: A Pilot Study." Int J Mol Sci 24(9).
Forgacova, N., Z. Holesova, R. Hekel, T. Sedlackova, Z. Pos, L. Krivosikova, P. Janega, K. M. Kuracinova, P. Babal, P. Radvak, J. Radvanszky, J. Gazdarica, J. Budis and T. Szemes (2023). "Evaluation and limitations of different approaches among COVID-19 fatal cases using whole-exome sequencing data." BMC Genomics 24(1): 12.
Milosavljevic, I., V. Jakovljevic, D. Petrovic, N. Draginic, J. Jeremic, M. Mitrovic, V. Zivkovic, I. Srejovic, V. Stojic, S. Bolevich and N. Andjelkovic (2021). "Standardized Aronia melanocarpa extract regulates redox status in patients receiving hemodialysis with anemia." Molecular and Cellular Biochemistry 476(11): 4167-4175.
Okabe, T., S. Togo, Y. Fujimoto, J. Watanabe, I. Sumiyoshi, A. Orimo and K. Takahashi (2020). "Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy." Cancers 12(12).
Zhao, Q., B. B. Li, Q. Gao, Y. Luo and L. Ming (2022). "Prognostic value of epithelial-mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis." Frontiers in Oncology 12.
Nicolas, E., B. Kosmider, E. Cukierman, H. Borghaei, E. A. Golemis and L. Borriello (2024). "Cancer treatments as paradoxical catalysts of tumor awakening in the lung." Cancer and Metastasis Reviews 43(4): 1165-1183.
Zhuang, Y., K. L. Su, S. S. Liu, W. Fan, H. J. Lv and W. Zhong (2025). "Clinical significances of RPL15 gene expression in circulating tumor cells of patients with breast cancer." Biomedical Reports 22(5).
09I03-03-V03-00046, BLAC-GPRO, Genetic profile variability in urinary bladder carcinoma; implications for diagnostics and therapy, funded by the EU through the Recovery and Resilience Plan for Slovakia. (2024-2026), key investigator.
APVV PP-COVID-20-0051, NECROCOV, Analysis of causes of death of patients and optimization of differential diagnosis in connection with SARS-CoV-2 infection in the Slovak Republic (2020-2022), co-investigator.
313011AVG3, BIOVID-19, Development of biomodels to improve the evaluation of the efficacy of drugs and agents that have potential in the treatment of COVID-19 (BIOVID-19), (2021-2023) co-investigator
313011W428 Centrum pre biomedicínsky výskum – BIOMEDIRES – II. Etapa, výzva OPVaI-VA/DP/2018/1.1.3-05, (2019-2023), spoluriešiteľ
VEGA 1/0646/25, Alterations in the placental tissue glycocode related to maternal glucose metabolism affecting the course of pregnancy. (2025-2027), principal investigator
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
Scientific Secretary | Student Scientific Board, Faculty of Medicine, Comenius University in Bratislava | 2010-2025 |
Scientific qualification degree IIa awarded 2.12.2011